The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Anneke M. Westermann

Department of Medical Oncology

Academic Medical Center

Amsterdam

Netherlands

[email]@amc.uva.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medical Oncology, Academic Medical Center, Amsterdam, Netherlands. 2005
  • Department of Medical Oncology, Antoni van Leeuwenhoekhuis/The Netherlands Cancer Institute, Amsterdam, Netherlands. 1999 - 2000

References

  1. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Westermann, A.M., Jones, E.L., Schem, B.C., van der Steen-Banasik, E.M., Koper, P., Mella, O., Uitterhoeve, A.L., de Wit, R., van der Velden, J., Burger, C., van der Wilt, C.L., Dahl, O., Prosnitz, L.R., van der Zee, J. Cancer (2005) [Pubmed]
  2. Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study. Westermann, A.M., Taal, B.G., Swart, M., Boot, H., Craanen, M., Gerritsen, W.R. Pharmacol. Res. (2000) [Pubmed]
  3. Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy. Westermann, A.M., Dubbelman, R., Baars, J.P., Moolenaar, W.H., Beijnen, J.H., Rodenhuis, S. Cancer Chemother. Pharmacol. (2000) [Pubmed]
  4. At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Westermann, A.M., Holtkamp, M.M., Linthorst, G.A., van Leeuwen, L., Willemse, E.J., van Dijk, W.C., Nooijen, W.J., Baars, J.W., Schornagel, J.H., Rodenhuis, S. Ann. Oncol. (1999) [Pubmed]
 
WikiGenes - Universities